Sanoma Corp
Sanoma Corporation, Stock Exchange Release, 2 March 2021 at 17:30 EET
Sanoma delivered company’s own shares based on share plans
Sanoma has today delivered a total of 210,363 own shares (without consideration and after taxes) to 130 employees of the Group as part of its long-term share-based incentive plans. More detailed information about the incentive plans is available on www.sanoma.com.
After the share delivery, Sanoma holds a total of 318,614 own shares.
Additional information
Kaisa Uurasmaa, Head of Investor Relations and Sustainability, tel. +358 40 560 5601
Sanoma
Sanoma is an innovative and agile learning and media company impacting the lives of millions every day.
Our learning products and services enable teachers to develop the talents of every child to reach their full potential. We offer printed and digital learning content as well as digital learning and teaching platforms for primary, secondary and vocational education, and want to grow our business across Europe.
Our Finnish media provide independent journalism and engaging entertainment also for generations to come. Our unique cross-media position offers the widest reach and tailored marketing solutions for our business partners.
Today, we operate in eleven European countries and employ close to 5,000 professionals. In 2020, our net sales amounted to approx. 1.1bn€ and our operational EBIT margin excl. PPA was 14.7%. Sanoma shares are listed on Nasdaq Helsinki. More information is available at www.sanoma.com.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG30.8.2025 17:00:00 CEST | Press release
Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
F. Hoffmann-La Roche Ltd30.8.2025 16:30:00 CEST | Press release
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
CGTN30.8.2025 11:44:44 CEST | Pressemeddelelse
CGTN: Arven efter Flying Tigers fejres for at styrke det varige bånd mellem Kina og USA
Sanofi Winthrop Industrie29.8.2025 23:50:03 CEST | Press release
Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
Northland Power Inc.29.8.2025 23:15:13 CEST | Press release
Northland Announces Reset Dividend Rate on Its Cumulative Rate Reset Preferred Shares, Series 1 & Series 2
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom